Describe the rationale behind dual pathway inhibition with combined anticoagulant and antiplatelet therapy Select appropriate patients for dual pathway inhibition following endovascular and surgical treatment of PAD Identify key operational processes to ensure consistent, standardized application of evidence-based therapies for treatment of PAD following endovascular and surgical revascularization across all care settings
- Provider:Amedco, LLC.
- Activity Link: https://acforum.org/web/index.php
- Start Date: 2024-12-20 06:00:00
- End Date: 2024-12-20 06:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
Nursing: 2.0 hours
Pharmacy: 2.0 hours - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Jointly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest